Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 5,343 | 8,260 | 11,785 | 15,005 | 24,066 |
| Cost of Goods | 410 | 3,490 | 2,057 | 3,559 | 4,052 |
| Gross Profit | 4,933 | 4,770 | 9,728 | 11,446 | 20,014 |
| Operating Expenses | 9,659 | 29,724 | 25,839 | 33,563 | 29,321 |
| Operating Income | -4,316 | -24,464 | -16,054 | -21,558 | -9,255 |
| Interest Expense | 2,333 | 0 | 1,219 | 1,139 | 490 |
| Other Income | 330 | -1,456 | 0 | 0 | 0 |
| Pre-tax Income | -6,319 | -25,920 | -17,273 | -22,697 | -9,745 |
| Net Income Continuous | -6,319 | -25,920 | -17,273 | -22,697 | -9,745 |
| Net Income Discontinuous | -4,855 | N/A | N/A | N/A | N/A |
| Net Income | $-11,174 | $-25,920 | $-17,273 | $-22,697 | $-9,745 |
| EPS Basic Total Ops | -5.20 | -14.00 | -11.60 | -18.60 | -8.60 |
| EPS Basic Continuous Ops | -3.00 | -14.04 | -11.57 | -18.58 | -8.60 |
| EPS Basic Discontinuous Ops | -2.20 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -5.20 | -14.00 | -11.60 | -18.60 | -8.60 |
| EPS Diluted Continuous Ops | -3.00 | -14.04 | -11.57 | -18.58 | -8.60 |
| EPS Diluted Discontinuous Ops | -2.20 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,527 | $-21,245 | $-14,868 | $-20,420 | $-5,766 |